These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25818769)

  • 1. Selective GPCR ligands.
    Gmeiner P
    Bioorg Med Chem; 2015 Jul; 23(14):3879. PubMed ID: 25818769
    [No Abstract]   [Full Text] [Related]  

  • 2. Bridging the gap: bitopic ligands of G-protein-coupled receptors.
    Lane JR; Sexton PM; Christopoulos A
    Trends Pharmacol Sci; 2013 Jan; 34(1):59-66. PubMed ID: 23177916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Ligands Illuminate GPCR Molecular Pharmacology.
    Wacker D; Stevens RC; Roth BL
    Cell; 2017 Jul; 170(3):414-427. PubMed ID: 28753422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SnapShot: GPCR-Ligand Interactions.
    Ghosh E; Nidhi K; Shukla AK
    Cell; 2014 Dec; 159(7):1712, 1712.e1. PubMed ID: 25525884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging structural insights into biased GPCR signaling.
    Shukla AK; Singh G; Ghosh E
    Trends Biochem Sci; 2014 Dec; 39(12):594-602. PubMed ID: 25458114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Computational Techniques to Study GPCR-Ligand Recognition.
    Ciancetta A; Sabbadin D; Federico S; Spalluto G; Moro S
    Trends Pharmacol Sci; 2015 Dec; 36(12):878-890. PubMed ID: 26538318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand and decoy sets for docking to G protein-coupled receptors.
    Gatica EA; Cavasotto CN
    J Chem Inf Model; 2012 Jan; 52(1):1-6. PubMed ID: 22168315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thematic Analysis™: a chemogenomic approach to GPCR drug discovery.
    Crossley R; Macritchie JA; Slater MJ
    Curr Top Med Chem; 2011; 11(15):1925-43. PubMed ID: 21470170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling G protein-coupled receptors and their interactions with ligands.
    Costanzi S
    Curr Opin Struct Biol; 2013 Apr; 23(2):185-90. PubMed ID: 23415855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and function of G protein-coupled receptor oligomers: implications for drug discovery.
    Schonenbach NS; Hussain S; O'Malley MA
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(3):408-27. PubMed ID: 25521522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a cyclic adenosine monophosphate assay for Gi-coupled G protein-coupled receptors by utilizing the endogenous calcitonin activity in Chinese hamster ovary cells.
    Wang Y; Kong Y; Shei GJ; Kang L; Cvijic ME
    Assay Drug Dev Technol; 2011 Oct; 9(5):522-31. PubMed ID: 21561374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein Activation in Drug Discovery - Part-I.
    Chen Q; Hao J
    Curr Top Med Chem; 2019; 19(24):2187. PubMed ID: 31769362
    [No Abstract]   [Full Text] [Related]  

  • 13. Biased ligands for better cardiovascular drugs: dissecting G-protein-coupled receptor pharmacology.
    DeWire SM; Violin JD
    Circ Res; 2011 Jul; 109(2):205-16. PubMed ID: 21737816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: GPCR-Targeted Drug Development.
    Sun L; Coy DH
    Curr Drug Targets; 2016; 17(5):486-7. PubMed ID: 26951060
    [No Abstract]   [Full Text] [Related]  

  • 15. Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives.
    Urwyler S
    Pharmacol Rev; 2011 Mar; 63(1):59-126. PubMed ID: 21228259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPCR Drug Discovery: Emerging Targets, Novel Approaches and Future Trends.
    Zhou J; Wild C
    Curr Top Med Chem; 2019; 19(16):1363-1364. PubMed ID: 31513505
    [No Abstract]   [Full Text] [Related]  

  • 17. Subtleties in GPCR drug discovery: a medicinal chemistry perspective.
    Fujioka M; Omori N
    Drug Discov Today; 2012 Oct; 17(19-20):1133-8. PubMed ID: 22732182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New winds in GPCR-based drug discovery.
    Lundstrom K
    Future Med Chem; 2016 Apr; 8(6):605-8. PubMed ID: 27105293
    [No Abstract]   [Full Text] [Related]  

  • 19. When simple agonism is not enough: emerging modalities of GPCR ligands.
    Smith NJ; Bennett KA; Milligan G
    Mol Cell Endocrinol; 2011 Jan; 331(2):241-7. PubMed ID: 20654693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New concepts in drug discovery: collateral efficacy and permissive antagonism.
    Kenakin T
    Nat Rev Drug Discov; 2005 Nov; 4(11):919-27. PubMed ID: 16264435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.